Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Afrezza Inhaler Device
Manufacturer/Marketed By : CIPLA LTD
$1.05 $0.94
The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Active Pharmaceutical Ingredient
Afrezza Inhaler Device
1,05$
0,94$
The Afrezza inhaler is a breath-powered device used to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is primarily prescribed for adults with type 1 or type 2 diabetes who need rapid-acting insulin to control blood sugar levels after meals. The Afrezza Inhaler effectiveness lies in its fast absorption through the lungs, which helps reduce post-meal glucose spikes. Unlike injections, this device offers a needle-free option for insulin delivery. The Afrezza Inhaler Device does not contain insulin on its own. It works only with Afrezza insulin cartridges that contain dry powder human insulin. The inhaler itself is reusable, while the cartridges are single-use and available in different strengths. Afrezza Inhaler dosage is decided by the doctor based on meal size, blood sugar readings, and individual insulin needs. Many patients ask, Is Afrezza safe for teenagers, and its use in younger individuals should be determined strictly by a healthcare professional. As with any insulin therapy, users should be aware of possible Afrezza Inhaler side effects, such as cough, throat irritation, or low blood sugar. Before starting therapy, patients should receive proper training to ensure correct inhalation technique and safe use. Those considering treatment often enquire about the Afrezza Inhaler price, which may vary depending on availability and pharmacy. Always consult a healthcare provider to confirm suitability and correct usage before starting Afrezza therapy.
Active Pharmaceutical Ingredient
Uses
• Mealtime blood glucose control in adults with type 1 diabetes (used in combination with long-acting basal insulin).
• Mealtime blood glucose control in adults with type 2 diabetes who require insulin therapy.
• Reduction of postprandial (after-meal) blood sugar spikes.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Common Side Effects:
Most Common Side Effects
• Bronchospasm
• Decline in lung function
• Severe hypoglycemia
• Allergic reactions
Common Side Effects
• Cough
• Throat irritation
• Hypoglycemia
• Headache
How To Use
To use the Afrezza Inhaler Device:
Safety Advice
• Pregnancy: Insulin therapy may be required during pregnancy, but the suitability of inhaled insulin should be assessed by a doctor.
• Breast Feeding: Limited data is available on the use of inhaled insulin during breastfeeding. Medical advice is recommended before use.
• Lungs: Afrezza is contraindicated in patients with chronic lung diseases such as asthma or COPD. Baseline and periodic lung function tests are required.
• Liver: Insulin requirements may vary in patients with liver impairment. Regular monitoring is advised.
• Alcohol: Alcohol can affect blood sugar control and increase the risk of hypoglycemia. Use with caution.
• Driving: Hypoglycemia can impair concentration and reaction time. Avoid driving if symptoms occur.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.